NSE: ONESOURCE | BSE: 544292

Expensive Performer

Download real time

1588.50 -55.90 (-3.40%)

29.34% Fall from 52W High

52,779 NSE+BSE Volume

NSE 22 Jan, 2026 11:27 AM (IST)

18,201.8

Market Cap

High in industry

Board Meeting

The next board meeting for OneSource Specialty Pharma is on 23 Jan 2026 for the purpose of Quarterly Results See details

OneSource Specialty Pharma Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for ONESOURCE, BSE:544292 OneSource Specialty Pharma Ltd.

Search Inside the pdf :

OneSource Specialty Pharma Ltd.

13 Nov 2025

1588.50

-3.40%

GLP-1 story delayed not derailed

Buy: OneSource Specialty Pharma...

ICICI Securities Limited

Delay in generic semaglutide approvals from Canadian regulator may shift the launch timeline by a quarter; however, with a few customers securing the approval in India and approvals in Brazil and Saudi Arabia expected to flow in, OneSource’s management remains confident of the upcoming opportunity, and hence, maintains FY28 guidance for its base business.

Promoters unpledged 7.52% of shares in last quarter. Total pledge stands at 18.52% of promoter holdings

RESEARCH REPORTS

Buy SEE REPORTS >

pdf